Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Edinburgh University trialling mycophenolate for Westie lung disease
The team is also collecting data on owner perception of the disease, as well as their experiences of disease development and progression, and treatment uses.
The research team is requesting interested colleagues to 'get in touch'. 

The University of Edinburgh Royal (Dick) School of Veterinary Studies (Dick Vet), is requesting clients and veterinary colleagues to get in contact regarding a mycophenolate trial for Westie lung disease cases.

In a letter to Vet Times (Volume 52, issue 4), Professor Brendan Corcoran explained that the university is conducting research to evaluate the efficacy of mycophenolate treatment for idiopathic pulmonary fibrosis (IPF) in West Highland white terriers (Westies).

A major cause of respiratory disability and respiratory failure in Westies, IPF currently has limited effective treatment options. The research team hope to validate a novel treatment option, as well as understanding owner perception of the disease.

Researchers are asking clients and interested veterinary colleagues to 'get in touch' – and if a case is discovered to have convincing evidence of IPF, the option to trial the use of mycophenolate will be offered.

The project is primarily remote based, however, cases can be seen at the Dick Vet as usual referrals.  

Preliminary work on the project has reportedly has 'promising success', particularly when diagnosis and disease severity have been confirmed by high-resolution CT.

The full letter is printed on page 23 of Vet Times Volume 52, Issue 4. Interested colleagues and clients can get in touch with the research team at westie.lungdisease@ed.ac.uk

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.